Literature DB >> 7487856

One-session therapist directed exposure vs two forms of manual directed self-exposure in the treatment of spider phobia.

K Hellström1, L G Ost.   

Abstract

Fifty-two patients with spider phobia, fulfilling the DSM-III-R criteria for simple phobia, were assessed with behavioral, physiological and self-report measures. They were randomly assigned to five different treatment conditions: (1) one session therapist-directed exposure (maximum 3 hours), (2) specific manual-based treatment in the home, (3) specific manual-based treatment at the clinic, (4) general manual-based treatment in the home and (5) general manual-based treatment at the clinic. The results show that therapist-directed one-session treatment was significantly more effective than three of the manual-based treatments, both at the post-treatment and follow-up stages. Specific manual-based treatment at the clinic was significantly more successful than the other manual-based treatments, but only at follow-up. The proportion of clinically significant improved patients at follow-up was 80% in the therapist-directed group compared to 63% for the specific manual-based treatment at the clinic, 10% for specific manual-based treatment in the home, 9% for general manual-based treatment in the home, and 10% for general manual-based treatment at the clinic. The conclusion that can be drawn is that one-session therapist-directed treatment is the treatment of choice for spider phobia but manual-based treatment is a good alternative in some cases.

Entities:  

Mesh:

Year:  1995        PMID: 7487856     DOI: 10.1016/0005-7967(95)00028-v

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  15 in total

Review 1.  The assessment and treatment of specific phobias: a review.

Authors:  Daniel F Grös; Martin M Antony
Journal:  Curr Psychiatry Rep       Date:  2006-08       Impact factor: 5.285

2.  Culturally adapted versus standard exposure treatment for phobic Asian Americans: Treatment efficacy, moderators, and predictors.

Authors:  David Pan; Stanley J Huey; Dominica Hernandez
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2011-01

Review 3.  Decision making about children's therapy.

Authors:  T Ronen
Journal:  Child Psychiatry Hum Dev       Date:  1993

4.  The role of courage on behavioral approach in a fear-eliciting situation: a proof-of-concept pilot study.

Authors:  Peter J Norton; Brandon J Weiss
Journal:  J Anxiety Disord       Date:  2008-07-12

5.  Extinction-reconsolidation boundaries: key to persistent attenuation of fear memories.

Authors:  Marie-H Monfils; Kiriana K Cowansage; Eric Klann; Joseph E LeDoux
Journal:  Science       Date:  2009-04-02       Impact factor: 47.728

6.  Large Group Exposure Treatment: a Feasibility Study in Highly Spider Fearful Individuals.

Authors:  André Wannemueller; David Appelbaum; Maike Küppers; Amelie Matten; Tobias Teismann; Dirk Adolph; Jürgen Margraf
Journal:  Front Psychol       Date:  2016-08-09

7.  In Vivo versus Augmented Reality Exposure in the Treatment of Small Animal Phobia: A Randomized Controlled Trial.

Authors:  Cristina Botella; M Ángeles Pérez-Ara; Juana Bretón-López; Soledad Quero; Azucena García-Palacios; Rosa María Baños
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

8.  Is Continued Improvement After Automated Virtual Reality Exposure Therapy for Spider Phobia Explained by Subsequent in-vivo Exposure? A First Test of the Lowered Threshold Hypothesis.

Authors:  Philip Lindner; Peter Dafgård; Alexander Miloff; Gerhard Andersson; Lena Reuterskiöld; William Hamilton; Per Carlbring
Journal:  Front Psychiatry       Date:  2021-05-20       Impact factor: 4.157

Review 9.  Moving from virtual reality exposure-based therapy to augmented reality exposure-based therapy: a review.

Authors:  Oliver Baus; Stéphane Bouchard
Journal:  Front Hum Neurosci       Date:  2014-03-04       Impact factor: 3.169

10.  Single-session gamified virtual reality exposure therapy for spider phobia vs. traditional exposure therapy: study protocol for a randomized controlled non-inferiority trial.

Authors:  Alexander Miloff; Philip Lindner; William Hamilton; Lena Reuterskiöld; Gerhard Andersson; Per Carlbring
Journal:  Trials       Date:  2016-02-02       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.